According to Nova one advisor, the global Isothermal Nucleic Acid Amplification Technology market was valued at USD 4.98 billion in 2022 and it is expected to hit around USD 11.9 billion by 2030 with a CAGR of 13.4% during the forecast period 2022 to 2030.
According to Nova one advisor, the global Isothermal Nucleic Acid Amplification Technology market was valued at USD 4.98 billion in 2022 and it is expected to hit around USD 11.9 billion by 2030 with a CAGR of 13.4% during the forecast period 2022 to 2030.
Get the Free Sample Copy of Report@ https://www.novaoneadvisor.com/report/sample/7532
Key Takeaways:
- By product, the reagents segment accounted for the largest market share in 2021 due to the widespread availability of thermo stable polymerases, and increasing demand for cost-effective diagnostic alternatives such as INAAT products
- Loop-mediated isothermal amplification (LAMP) technology accounted for the largest share of 15.83% in 2021 as the technique allows for the use of multiple modes of detection and has the ability to detect a broad range of RNA and DNA targets
- By application, infectious disease diagnostics held the largest share of 34.84% in 2021. This can be attributed to the rising prevalence of infectious disease, globally, and promising alternatives offered by INAAT technologies over PCR-based techniques
- North America held a share of 42.86% and dominated the global market in 2021, due to the rapid growth in the healthcare sector and the presence of key players such as Thermo Fisher Scientific, Inc., Quidel Corporation, Meridian Bioscience, Inc., and others within the region
- Hospitals end-use segment held the largest market share of 39.83% in 2021 due to the increasing adoption of INAAT techniques for rapid diagnostics and increasing global healthcare expenditure
Report Scope of the Isothermal Nucleic Acid Amplification Technology Market
| Report Coverage | Details |
| Market Size | USD 11.9 Billion by 2030 |
| Growth Rate | CAGR of 13.4% from 2022 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, technology, application, end-use and Region, |
Immediate Delivery Available | Buy this Premium Research Report@ https://www.novaoneadvisor.com/report/checkout/7532
A significant rise in awareness regarding the rapid testing and early detection of chronic and infectious diseases is expected to be a significant factor driving the market growth. Furthermore, the global growth in the prevalence of HIV, hepatitis, and sexually transmitted diseases, as well as the rise in adoption of INAAT for the diagnosis of such diseases, is anticipated to drive market growth.
INAAT offers a more sensitive, accurate, and rapid alternative to traditional methods, such as culture-based identification, for the diagnosis of infectious diseases. Similarly, INAAT techniques require minimal resources and are used without the need for thermal cyclers, which significantly improves the portability of such techniques. Moreover, isothermal amplification involves the use of less expensive procedures and equipment, which can fuel its adoption in developing countries. In particular, regions such as the Asia Pacific and Africa, that have recently witnessed epidemics of infectious diseases, such as Zika virus, tuberculosis, and influenza, present significant opportunities for market expansion.
To address the growing demand for INAAT offerings, key players are expanding their product portfolio by the launch of advanced reagents for the latest INAAT products. For instance, in March 2022, Thermo Fisher Scientific, Inc. launched its Invitrogen Super Script IV RT-LAMP Master Mix, intended for the detection of various viral pathogens. Such product launches are favoring market growth by increasing the utility of INAAT techniques for a broad range of applications.
Furthermore, COVID-19 has positively affected the market growth by increasing demand for the rapid and accurate testing alternatives used for the detection of the SARS-CoV-2 virus. Several key players have developed new INAAT-based COVID-19 testing products and have secured emergency use approvals for such products from the U.S. FDA. For instance, commercially available products in this domain include Grifols Diagnostic Solutions Inc.’s Procleix SARS-CoV-2 assay and Lucira Health, Inc.’s Lucira CHECK-IT COVID-19 test kit. Such strategic initiatives fueled by COVID-19 are likely to provide a significant stimulus to market growth in the near future.
Regional Insights
North America held the largest market share in 2021 due to the established research infrastructure and growth in demand for nucleic acid amplification-based diagnostics intended to prevent infectious diseases in the region. Furthermore, a high per capita expenditure on healthcare and increasing focus on point-of-care diagnostic methods is anticipated to drive market growth.
INAAT market for Germany held a substantial share in 2021 due to the ageing population of the country and significant focus on the healthcare systems. According to the World Bank, the country’s population over 65 years of age was estimated to account for a 21.98% share of the total population in 2021. As a result, a such high proportion of the geriatric population is expected to lead to a high prevalence of age-related disorders that can strengthen market prospects for effective INAAT devices.
Some of the prominent players in the Isothermal Nucleic Acid Amplification Technology Market include:
- Alere, Inc.
- bioMerieux SA
- Eiken Chemical Co. Ltd
- Hologic Inc.(Gen-Probe)
- Lucigen
- Meridian Bioscience, Inc.
- Ustar Biotechnologies Ltd.
- QIAGEN
- Quidel Corporation
- Thermo Fisher Scientific, Inc.
- BD (Becton, Dickinson & Company)
- OptiGene Limited
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Isothermal Nucleic Acid Amplification Technology market
- Product
- Instruments
- Reagent
- Technology
- NASBA
- HDA
- LAMP
- SDA
- SPIA
- NEAR
- TMA
- RCA
- RPA
- SMAP2
- Others
- Application
- Blood Screening
- Infectious Disease Diagnostics
- Cancer
- Others
- End-use
- Hospitals
- Central & Reference Labs
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Full Report is Ready | For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/7532
You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
Blog: https://qyresearchmedical.com/